ClinicalTrials HQ
Back
Australia Victoria South Yarra Acf1c8c9
Australia Victoria South Yarra Acf1c8c9
Australia Victoria South Yarra Acf1c8c9
South Yarra
South Yarra
South Yarra, Victoria, Australia
Search
10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
Trial
Conditions
Status
Phase
Updated
More info
NCT ID
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Neoplasms by Site, Skin and Connective Tissue Diseases, neoplasm, skin disorder, skin neoplasm
Recruiting
Phase 3
2026-09-16
More info
NCT06585410
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Acute Myocardial Infarction (AMI); Cardiovascular Risk
Active, not recruiting
Phase 3
2026-09-09
More info
NCT06118281
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
HIV-1-infection
Recruiting
Phase 2
2026-09-04
More info
NCT07645287
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypopigmentation of the skin, hypotrichosis, skin disorder, skin pigmentation disorder, vitiligo
Active, not recruiting
Phase 1
2026-07-08
More info
NCT06602232
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy
HIV-1-infection
Active, not recruiting
Phase 3
2026-06-15
More info
NCT06333808
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
Subcutaneous Fat
Recruiting
Phase 2
2026-06-04
More info
NCT07608770
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
Subcutaneous Fat
Not yet recruiting
Phase 2
2026-05-29
More info
NCT07608757
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1
HIV-1-Infection
Active, not recruiting
Phase 3
2026-05-29
More info
NCT06630299
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1
HIV-1-infection
Active, not recruiting
Phase 3
2026-04-30
More info
NCT06630286
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.
Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorder
Recruiting
Phase 1
2025-11-20
More info
NCT07205159
Previous
1 / 1
Next